Nareg H. Roubinian, MD, MPHTM



Clinical Science

Dr. Nareg Roubinian is a Senior Physician in pulmonary and critical care medicine at Kaiser Permanente Oakland and Richmond Medical Centers. He has an extensive background in research and education. He serves as a local research chair and is an adjunct investigator at the Kaiser Permanente Northern California Division of Research. His research addresses topics in epidemiology and outcomes of blood transfusion, COVID-19, and venous thromboembolism. As an associate program director, Dr. Roubinian also helps lead the Kaiser Permanente Northern California Pulmonary and Critical Care Medicine fellowship program. At KPSOM, Dr. Roubinian is involved in faculty development with an emphasis on appointments and promotions for the Clinical Science faculty.

Faculty profile headshot of Nareg H. Roubinian, MD, MPHTM

Education and Training

BS, University of California, Berkeley
MD, Larner College of Medicine at the University of Vermont
MPHTM, Tulane University School of Public Health and Tropical Medicine
Postdoctoral Training
Internship, Residency, Internal Medicine, Washington University in Saint Louis
Fellowship, Pulmonary and Critical Care Medicine, UCSF Medical Center

Professional Positions

Assistant Clinical Professor, Department of Medicine
UCSF School of Medicine
Assistant Adjunct Professor, Department of Laboratory Medicine
UCSF School of Medicine
Affiliate Investigator
Vitalant Research Institute
Senior Physician, Pulmonary and Critical Care Medicine
Kaiser Permanente Oakland Medical Center
Adjunct Investigator
Kaiser Permanente Division of Research
Associate Adjunct Professor, Department of Laboratory Medicine
UCSF School of Medicine
Associate Program Director, Pulmonary and Critical Care Medicine Fellowship Program
Kaiser Permanente Oakland Medical Center
Professor, Department of Clinical Science
Kaiser Permanente Bernard J. Tyson School of Medicine

Honors and Awards

Morris Collen Research Award
The Permanente Research Group

Scholarly Activities

Selected peer-reviewed research manuscripts
  • Roubinian NH, Hendrickson JE, Triulzi DJ, Gottschall JL, Michalkiewicz M, Chowdhury D, Kor DJ, Looney MR, Matthay MA, Kleinman SH, Brambilla D, Murphy EL; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload. Crit Care Med. 2018 Apr;46(4):577-585. doi: 10.1097/CCM.0000000000002948. PMID: 29300236; PMCID: PMC5851817.
  • Roubinian NH, Murphy EL, Mark DG, Triulzi DJ, Carson JL, Lee C, Kipnis P, Kleinman S, Liu VX, Escobar GJ. Long-Term Outcomes Among Patients Discharged From the Hospital With Moderate Anemia: A Retrospective Cohort Study. Ann Intern Med. 2019 Jan 15;170(2):81-89. doi: 10.7326/M17-3253. Epub 2018 Dec 18. PMID: 30557414; PMCID: PMC6639156.
  • Roubinian NH, Dusendang JR, Mark DG, Vinson DR, Liu VX, Schmittdiel JA, Pai AP. Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California. JAMA Intern Med. 2021 Jul 1;181(7):997-1000. doi: 10.1001/jamainternmed.2021.0488. Erratum in: JAMA Intern Med. 2021 Dec 1;181(12):1679. PMID: 33818615; PMCID: PMC8022258.
  • Roubinian NH, Reese SE, Qiao H, Plimier C, Fang F, Page GP, Cable RG, Custer B, Gladwin MT, Goel R, Harris B, Hendrickson JE, Kanias T, Kleinman S, Mast AE, Sloan SR, Spencer BR, Spitalnik SL, Busch MP, Hod EA; National Heart Lung and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study IV Pediatrics (REDS-IV-P). Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness. JCI Insight. 2022 Jan 11;7(1):e152598. doi: 10.1172/jci.insight.152598. PMID: 34793330; PMCID: PMC8765041.
  • Edgren G, Murphy EL, Brambilla DJ, Westlake M, Rostgaard K, Lee C, Cable RG, Triulzi D, Bruhn R, St Lezin EM, Erikstrup C, Ullum H, Glynn SA, Kleinman S, Hjalgrim H, Roubinian NH; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) Group. Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients. JAMA. 2019 Jun 11;321(22):2183-2192. doi: 10.1001/jama.2019.7084. PMID: 31184739; PMCID: PMC6563535.
  • Roubinian NH, Plimier C, Woo JP, Lee C, Bruhn R, Liu VX, Escobar GJ, Kleinman SH, Triulzi DJ, Murphy EL, Busch MP. Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion. Blood. 2019 Sep 26;134(13):1003-1013. doi: 10.1182/blood.2019000773. Epub 2019 Jul 26. PMID: 31350268; PMCID: PMC6764268.
  • Custer B, Bloch EM, Bryant BJ, D'Alessandro A, Delaney M, Goel R, Hod EA, Josephson CD, Katz LM, Miller YM, Sayers MH, Seheult JN, Triulzi DJ, Berger J, Zou S, Hailu B, Glynn SA, Roubinian NH. Proceedings of the 2022 NHLBI and OASH state of the science in transfusion medicine symposium. Transfusion. 2023 May;63(5):1074-1091. doi: 10.1111/trf.17296. Epub 2023 Apr 2. PMID: 37005871.
  • Roubinian NH, Vinson DR, Pai AP, Myers LC, Skarbinski J, Lee C, Mark DG, Liu VX. Risk of VTE in Nonrespiratory and Respiratory Presentations of COVID-19 in Critically Ill Patients. Chest. 2023 Jul;164(1):215-218. doi: 10.1016/j.chest.2023.02.008. Epub 2023 Feb 12. PMID: 36787875; PMCID: PMC9922435.
  • Roubinian NH, Greene J, Liu VX, Lee C, Mark DG, Vinson DR, Spencer BR, Bruhn R, Bravo M, Stone M, Custer B, Kleinman S, Busch MP, Norris PJ; NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-P (REDS-IV). Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS-CoV-2 infection and vaccination. Transfusion. 2024 Jan;64(1):53-67. doi: 10.1111/trf.17616. Epub 2023 Dec 6. PMID: 38054619; PMCID: PMC10842807.
  • Nemkov T, Stephenson D, Erickson C, Dzieciatkowska M, Key A, Moore A, Earley EJ, Page GP, Lacroix IS, Stone M, Deng X, Raife T, Kleinman S, Zimring JC, Roubinian N, Hansen KC, Busch MP, Norris PJ, D'Alessandro A. Regulation of kynurenine metabolism by blood donor genetics and biology impacts red cell hemolysis in vitro and in vivo. Blood. 2024 Feb 1;143(5):456-472. doi: 10.1182/blood.2023022052. PMID: 37976448; PMCID: PMC10862365.
  • View a complete list of Dr. Roubinian's manuscripts